Skip to content

Study on the prevalence and risk factors of eosinophilic esophagitis in patients with bronchial asthma

Study on the prevalence and risk factors of eosinophilic esophagitis in patients with bronchial asthma - Study on the prevalence and risk factors of eosinophilic esophagitis in patients with bronchial asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000009815
Enrollment
1000
Registered
2013-02-01
Start date
2012-12-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

eosinophilic esophagitis bronchial asthma

Interventions

gastrointestinal fiberscopy

Sponsors

Shimane universitu faculty of medicine
Lead Sponsor
Matsue Red Cross Hospital Matsue City Hospital Hamada medical center Yonago medical center
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with bronchial asthma diagnosed by pulmonary physician. written informed concent.

Exclusion criteria

Exclusion criteria: receiving systemic glucocorticoids.

Design outcomes

Primary

MeasureTime frame
prevalence rate of the eosinophilic esophagitis among the patients with bronchial asthma

Countries

Japan

Contacts

Public ContactYoshikazu Kinoshita

Shimane university faculty of medicine second department of internal medicine

kinosita@med.shimane-u.ac.jp+81-853-20-2190

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026